Dmitry is a recognized expert in RNAi technology and brings 15+ years of scientific, technology, and business development leadership experience at RNAi companies in the US, Asia, and Europe. Most recently he served as a Chief Scientific Officer at Silence Therapeutics (UK, Germany). Dmitry’s role is to secure Sirnaomics’ position as a leader in RNAi technology and to initiate and facilitate pharma partnering discussions.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Sirnaomics | Chief Technology Officer | Jan 1, 2018 | — | Detail |